Introduction
Cardiopulmonary bypass (CPB) with extracorporeal circulation (ECC) results in major haematological changes including leukocytosis and thrombocytopenia. The release of several inflammator compounds including cytokines, eicosanoids, platelet-activating factor (PAF), and activation of the coagulation and the complement cascade are suspected to play a role in these haematological disorders and in the pathogenesis of the inflammatory syndrome observed after CPB. [2] [3] [4] [5] [6] Monocte/macrophage activation accompanies CPB. Macrophage colony-stimulating factor (M-CSF), also known as CSF-1, is a major regulator of the production as well as functional state of cells of the mononuclear-phagocytic lineage. 8 were found at the 6th (7.3 +0.7IU/ml/btg protein) and 24th (8.6 -q-0.8 IU/ml/gg protein) postoperative hour compared with To (4.9-+-0.5 IU/ml/pg protein).
A positive correlation was observed before (To) and during ECC (T1) between platelet counts and M-CSF concentrations (Table 2) . After cross-clamp release no correlation was found between platelet counts and M-CSF concentrations. No correlation was found between M-CSF concentrations and leukocyte counts at any blood sampling time (Table 2) .
No difference was documented between M-CSF concentrations according to the grade of haematological complications at T3, T4 and T5 (Fig. 3) .
Discussion
This study shows that plasma M-CSF concentrations are stable during ECC and increase at the 6th and 24th postoperative hour compared with pre-ECC values. While lipidic mediators are produced chiefly during ECC, 7'8 elevated cytokine concentrations are often found after few hours. 5 [8] [9] [10] [11] [12] [13] In addition elevated circulating amounts of granulocyte-CSF (G-CSF) have been recently found after cardiac surgery,
